NPC
ALBO

National Planning Corporation’s Albireo Pharma Inc ALBO Stock Holding History

National Planning Corporation’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-83
Closed -$3.63K – 2194
2014
Q4 		$3.63K Buy
+83
New +$3.64K ﹤0.01% 2430

Other funds holding ALBO

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

National Planning Corporation's ALBO Position: Q1 2015 in Review

National Planning Corporation sold out of Albireo Pharma Inc (ALBO) in Q1 2015, closing a stake of 83 shares — an estimated $3.63K sold.

National Planning Corporation first reported a position in ALBO in Q4 2014 and held it in 1 quarter. The position peaked at $3.63K in Q4 2014. 34 funds tracked by Wall St. Rank hold ALBO as of Q1 2015.

  • National Planning Corporation reported no remaining Albireo Pharma Inc position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 83 Albireo Pharma Inc shares in Q1 2015, an estimated $3.63K.
  • National Planning Corporation first reported a position in Albireo Pharma Inc in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's Albireo Pharma Inc position peaked at $3.63K in Q4 2014.
  • 34 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.